drugset / Trial / NCT00091182
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying how well oxaliplatin works in treating young patients with recurrent solid tumors that have not responded to previous treatment. Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | Intravenous |
Indications
Ewing sarcoma/peripheral primitive neuroectodermal tumor
adrenal cortex carcinoma
childhood brain stem glioma
childhood central nervous system germ cell tumor
childhood cerebellar astrocytic neoplasm
childhood ependymoma
childhood testicular germ cell tumor
hepatoblastoma
low-grade astrocytoma
malignant childhood germ cell neoplasm
nasopharyngeal carcinoma
neuroblastoma
osteosarcoma
pediatric hepatocellular carcinoma
pediatric high-grade glioma
pediatric ovarian germ cell tumor
rectal cancer
rhabdomyosarcoma
teratoma